Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Dopamine goes from pleasure to repair molecule

Nov. 5, 2019

Rightsizing brain activity increases lifespan, but REST is not all good

Oct. 31, 2019

Blade Therapeutics identifies new calpain inhibitors

Oct. 23, 2019

Mitochondrial mutations hamper nuclear DNA repair

Oct. 14, 2019

Potent new small-molecule inhibitors block apoptosis in mice

Oct. 11, 2019

Calling bias sinks CCR5 work, but is "likely unique" to variant

Oct. 10, 2019

Three win Nobel for hypoxia work

Oct. 8, 2019

Aerie Pharmaceuticals synthesizes new kinase inhibitors

Oct. 8, 2019

Pliant Therapeutics describes integrin alphavbeta6 antagonists

Sep. 27, 2019

Bone-deep stress

Sep. 20, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...